First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.
Publication
, Journal Article
Vasavda, C; Ho, BK; Zhang, DY; Williams, KA; Kaffenberger, BH; Kwatra, SG; Kwatra, MM
Published in: Br J Dermatol
December 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
December 2020
Volume
183
Issue
6
Start / End Page
1105 / 1107
Location
England
Related Subject Headings
- Protein Kinase Inhibitors
- Phosphoproteins
- Humans
- ErbB Receptors
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vasavda, C., Ho, B. K., Zhang, D. Y., Williams, K. A., Kaffenberger, B. H., Kwatra, S. G., & Kwatra, M. M. (2020). First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol, 183(6), 1105–1107. https://doi.org/10.1111/bjd.19263
Vasavda, C., B. K. Ho, D. Y. Zhang, K. A. Williams, B. H. Kaffenberger, S. G. Kwatra, and M. M. Kwatra. “First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.” Br J Dermatol 183, no. 6 (December 2020): 1105–7. https://doi.org/10.1111/bjd.19263.
Vasavda C, Ho BK, Zhang DY, Williams KA, Kaffenberger BH, Kwatra SG, et al. First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol. 2020 Dec;183(6):1105–7.
Vasavda, C., et al. “First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.” Br J Dermatol, vol. 183, no. 6, Dec. 2020, pp. 1105–07. Pubmed, doi:10.1111/bjd.19263.
Vasavda C, Ho BK, Zhang DY, Williams KA, Kaffenberger BH, Kwatra SG, Kwatra MM. First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol. 2020 Dec;183(6):1105–1107.
Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
December 2020
Volume
183
Issue
6
Start / End Page
1105 / 1107
Location
England
Related Subject Headings
- Protein Kinase Inhibitors
- Phosphoproteins
- Humans
- ErbB Receptors
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences